Cheryl A. Hillery, MD, is clinical director of Hematology at UPMC Children’s Hospital of Pittsburgh and a professor of Pediatrics within the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine. She is the director of the Pediatric Comprehensive Sickle Cell Program and has led basic, translational, and clinical research studies focused on sickle cell disease. Dr. Hillery is highly rated in 6 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology.Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis.He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health.Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection.View the full list of Dr. Xavier’s publications on PubMed. Dr. Xavier is highly rated in 5 conditions, according to our data. His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD).

Jean M. Tersak, MD, provides care for pediatric oncology patients and long term survivors of childhood cancer at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is institutional principal investigator for the UPMC Children’s Oncology Group and director of clinical oncology research within the Division of Pediatric Hematology/Oncology. She is also a professor of pediatrics and clinical and translational science at the University of Pittsburgh School of Medicine and is board-certified in pediatric hematology/oncology.Dr. Tersak earned her bachelor's degree, master’s degree, and  medical degree from the University of Pittsburgh. She completed her residency and fellowship at UPMC Children’s Hospital of Pittsburgh.Dr. Tersak is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis. Her research interests include the late effects, quality of life, and neurocognitive outcomes in survivors of childhood cancer and evaluation and treatment of opsoclonus myoclonus in patients with neuroblastoma. She is a member of the American Society of Clinical Oncology Children’s Oncology Group.View the full list of Dr. Tersak’s publications on PubMed. Dr. Tersak is highly rated in 17 conditions, according to our data. Her top areas of expertise are Neuroepithelioma, Neuroblastoma, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Aspiration.

Dr. Ramdas is a fellowship-trained specialist in pediatric hematology/oncology and board certified in pediatrics. His clinical interests include general pediatric hematology and oncology; childhood cancer (e.g., leukemia, lymphoma, brain tumor, neuroblastoma, Wilms' tumor, bone tumor, soft tissue sarcoma); and pediatric hematology (e.g., anemia, thrombocytopenia, neutropenia, bone marrow failure, sickle cell disease, bleeding disorders, ITP). Dr. Ramdas earned his medical degree from Calcutta National Medical College in India. He then moved to the United States to complete his residency and a fellowship in pediatric hematology and oncology at Louisiana State University. Dr. Ramdas is certified by the American Board of Pediatrics in pediatrics and in pediatric hematology-oncology. Dr. Ramdas is highly rated in 9 conditions, according to our data. His top areas of expertise are Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, Hepatoblastoma, and Bone Marrow Aspiration.

James Felker, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is assistant professor of medicine at the University of Pittsburgh School of Medicine. Dr. Felker received his medical degree from New York Medical College and completed his residency at Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago followed by a fellowship in pediatric hematology/oncology and neuro-oncology at Emory University/Children’s Healthcare of Atlanta, Ga. Dr. Felker’s clinical interests include pediatric brain and spinal tumors and clinical trial development. He has published numerous articles in peer-reviewed journals and is a member of the American Society of Pediatric Hematology/Oncology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, and the Pediatric Brain Tumor Consortium. His wife is a pediatric cardiologist at UPMC Children’s and has an interest in long term cardiac outcomes for oncology patients. Together they have two girls and a beagle mutt. Dr Felker enjoys running along the rivers in Pittsburgh while trying to avoid the hills.View the full list of Dr. Felker's publications on PubMed.View Dr. Felker's profile at the University of Pittsburgh School of Medicine – Department of Pediatrics.LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Felker is highly rated in 3 conditions, according to our data. His top areas of expertise are Brain Stem Cancer, Glioma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.

James Cooper, MD, MSc, is clinical director of the Coagulation Program at UPMC Children's Hospital of Pittsburgh. He is also an assistant professor of pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology and pediatrics.Dr. Cooper earned his medical degree from University of Connecticut School of Medicine. He completed a residency and internship in pediatrics at the University of Connecticut-Connecticut Children's Medical Center followed by a fellowship in pediatric hematology-oncology at UPMC Children's Hospital. Dr. Cooper also earned his master's of science in clinical research at the University of Pittsburgh Institute for Clinical Research Education.In his role as clinical director of the Coagulation Program, Dr. Cooper cares for children with bleeding disorders and thrombosis concerns. As part of that mission, Dr. Cooper and Dr. Tahniat Syed of Adolescent Medicine co-lead a dedicated clinic for young women with menstrual disorders, known as the CHAMP (Comprehensive Hematologic Assessment of Adolescents with Menstrual Problems) Clinic. In addition to coagulation disorders, Dr. Cooper also cares for children with a variety of oncologic and other hematologic problems.Dr. Cooper’s research interests include thrombosis rates in adolescents and young adults versus younger children with cancer and the cost effectiveness of laboratory analysis of clotting disorders in children. He is a member of the American Society of Pediatric Hematology and Oncology, the American Society of Hematology, the Children’s Oncology Group, the Critical Mass Young Adult Alliance, the American Thrombosis & Hemostasis Network, the American Academy of Pediatrics, the Foundation for Women and Girls with Bleeding Disorders, and the Hemostasis and Thrombosis Research Society.View the full list of Dr. Cooper’s publications on PubMed. Dr. Cooper is highly rated in 2 conditions, according to our data. His top areas of expertise are Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), Hemophilia A, and Blood Clots.

Julia Meade, MD, is a pediatric genetic oncologist certified in pediatric hematology/oncology by the American Board of Pediatrics. She is an Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine in both the divisions of Pediatric Hematology/Oncology and Genetic and Genomic Medicine. Dr. Meade holds a secondary appointment as Associate Professor of Human Genetics in the School of Public Health. She received her medical degree from Texas A&M University School of Medicine and completed her pediatric residency at the University of Colorado, followed by her hematology/oncology fellowship at UT Southwestern Medical Center and her pediatric neuro-oncology fellowship at Northwestern University. Dr. Meade also holds a certificate in cancer risk assessment from the City of Hope. Dr. Meade is highly rated in 1 condition, according to our data. Her top areas of expertise are Ewing Sarcoma, Osteosarcoma, L1 Syndrome, and Medulloblastoma.

Angela Waanders is a Pediatric Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Waanders is highly rated in 16 conditions, according to our data. Her top areas of expertise are Glioma, Medulloblastoma, Optic Glioma, and Diffuse Midline Glioma H3 K27M-Mutant.

View the full list of Dr. Friehling's publications on PubMed. Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Chromosome 7p Deletion, Leukemia, and Juvenile Myelomonocytic Leukemia (JMML).

Lisa Maurer, MD, PhD, is a pediatric oncologist with an interest in pediatric leukemia and lymphoma. She is also a physician-scientist in the Lucas/ McAllister Lab in the Rangos Research Center of the UPMC Children's Hospital of Pittsburgh. Currently, Dr. Maurer's research focus is on the role of GRK2 in inhibition of the MALT1 proto-oncoprotein in lymphomagenesis.Dr. Maurer earned her medical degree from University of Wisconsin School of Medicine and Public Health and her PhD from the University of Wisconsin-Madison. She completed an internship and residency at the University of California San Francisco followed by a fellowship at UPMC Children’s Hospital of Pittsburgh.She is a member of the American Society of Pediatric Hematology Oncology and the AACR.View the full list of Dr. Maurer’s publications on PubMed. Her top areas of expertise are Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Embryonal Tumor with Multilayered Rosettes.

View the full list of Dr. Rapkin's publications on PubMed. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Rhabdoid Tumor, Non-Langerhans-Cell Histiocytosis, and Reticulohistiocytoma.

Felipe Bautista is a Pediatric Hematologist Oncology provider in Allentown, Pennsylvania. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Classical Hodgkin Lymphoma, and Bone Marrow Aspiration.

View the full list of Dr. Nolfi's publications on PubMed. Her top areas of expertise are Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), and Splenectomy.

Ramasubramanian (“Ram”) Kalpatthi, MD, is Clinical Research Director of Pediatric Sickle Cell Research and Director of PHO Medical Student and Resident Education at UPMC Children's Hospital of Pittsburgh. He is also a Visiting Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology.He earned his medical degree from Thanjavur Medical College in Thanjavur, India. He completed a Residency at All India Institute of Medical Sciences and Lincoln Medical Center followed by a fellowship at Nationwide Children's Hospital.Dr. Kalpatthi is nationally recognized for his excellence in the clinical care, clinical research, program development and leadership in the field of pediatric hematology oncology with special emphasis on sickle cell disease (SCD) and immune thrombocytopenia (ITP). His other clinical interests include therapeutic apheresis, immune hematological disorders, neonatal hematology, benign hematological disorders, and childhood leukemia.Also, he is a favorite among medical students, residents, and fellows due to his passion for teaching, guiding, and mentoring future generation of physicians. He has mentored medical students, residents, and fellows in completing clinical research projects that have been published and/or presented at national conferences such as the American Society of Hematology (ASH), the American Society of Pediatric Hematology/Oncology (ASPHO) and Pediatric Academic Societies (PAS) meeting. Several of his mentees received outstanding abstract achievement awards for their work and most of his mentees have published their research in leading medical journals.View the full list of Dr. Kalpatthi’s publications on PubMed. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.

View the full list of Dr. Bukowinski's publications on PubMed. His top areas of expertise are Adult Soft Tissue Sarcoma, Leukemia, Rhabdomyosarcoma, and Osteosarcoma.

Scott Maurer, MD, is a pediatric palliative care physician and a pediatric oncologist. Dr. Maurer is certified in pediatrics, pediatric hematology/oncology, and hospice and palliative medicine by the American Board of Pediatrics. He is the chief of the division of palliative medicine and supportive care at UPMC Children’s Hospital of Pittsburgh and is an associate professor of pediatrics at the University of Pittsburgh School of Medicine. His top areas of expertise are Infantile Neutropenia, Rosai-Dorfman Disease, Pediatric Low-Grade Glioma (pLGG), and Leukemia.

Jenny Ruiz, MD, specializes in pediatric hematology oncology and is board certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Hematology/Oncology and is affiliated with UPMC Magee-Womens Hospital. Dr. Ruiz completed her fellowship at Children's Hospital of Philadelphia, residency at Columbia University, and medical education at Columbia University College of Physicians and Surgeons. Her top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma.

A. Kim Ritchey, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is vice-chair of International Affairs of the Department of Pediatrics at UPMC Children’s Hospital of Pittsburgh and is professor of pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Cincinnati School of Medicine and completed his pediatric residency at Johns Hopkins Hospital, followed by his fellowship in pediatric hematology/oncology at Yale University. Dr. Ritchey’s clinical interests include all aspects of pediatric hematology and oncology. His career focus is pediatric leukemia and coagulation disorders. He has numerous publications in peer-reviewed journals as well as book chapters and has presented both locally and nationally. He is a member of the American Society of Pediatric Hematology/Oncology where he served as president, as well as the American Society of Hematology, and the American Society of Clinical Oncology. His top areas of expertise are Childhood Pancreatitis, RASopathies, Infantile Neutropenia, and Mast Cell Activation Syndrome (MCAS).

Jennifer Ann Kovatch, MD, is a board-certified physician specializing in pediatric hematology oncology.|Dr. Kovatch and her team treat children up to age 13 for conditions such as leukemia/lymphoma, solid tumors, benign tumors and benign hematology (anemia, bleeding disorders and clotting disorders).|Dr. Kovatch performs procedures including lumbar puncture, intrathecal chemotherapy (when chemotherapy is delivered into cerebrospinal fluid), and bone marrow aspiration and biopsy.|She was inspired by her own experience as a pediatric hematology oncology patient to pursue a career in medicine and make a difference in the lives of children. “I love getting to know my patients and helping them achieve their therapeutic goals,” she says.|Dr. Kovatch earned her Doctor of Medicine from the Ross University School of Medicine in the West Indies in 2014. She completed her residency at the University of Missouri in 2017 and a fellowship at the Penn State College of Medicine in 2020.|She is board certified in pediatrics and pediatric hematology oncology by the American Board of Pediatrics.|A New Jersey native, Dr. Kovatch enjoys renovating her home, yardwork and fostering cats in her spare time. Her hobbies include riding her motorcycle and creating artwork. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1).

View the full list of Dr. Seynnaeve’s publications on PubMed. Her top area of expertise is Saddle Pulmonary Embolism.

Benison Lau, MD, specializes in pediatric hematology oncology and is board-certified in pediatrics by the American Board of Pediatrics and internal medicine and American Board of Internal Medicine. He is affiliated with UPMC Children's Hospital of Pittsburgh. Dr. Lau completed his residency at the University of Massachusetts Medical School and medical degree at the University of Illinois College of Medicine at Peoria. His top areas of expertise are Glioma, Thalassemia, Diffuse Midline Glioma H3 K27M-Mutant, Immune Thrombocytopenic Purpura (ITP), and Deep Brain Stimulation.

Colleen Mathews, MD, specializes in pediatric hematology oncology and is board-certified in pediatrics by the American Board of Pediatrics. She practices at Pediatric Hematology Oncology in Lawrenceville and is affiliated with UPMC Children's Hospital of Pittsburgh and UPMC Magee-Womens Hospital. Dr. Mathews completed her fellowship at University of Pittsburgh School of Medicine, residency at University of Louisville School of Medicine, and medical education at Saint Louis University School of Medicine. Her top area of expertise is Jaundice.

Dr. Miller is a board-certified and fellowship-trained specialist in pediatric hematology/oncology. She attended Eastern Virginia Medical School, where she received her medical degree. She completed her residency at Geisinger Medical Center and her fellowship in pediatric hematology and oncology at the University of Iowa Hospitals and Clinics. Dr. Miller is certified by the American Board of Pediatrics in pediatric hematology-oncology. Her top areas of expertise are Neurofibromatosis Type 1 (NF1) and Immune Thrombocytopenic Purpura (ITP).

Jaxon Vallely, DO, specializes in pediatric hematology oncology and pediatric palliative medicine and is board-certified by the American Board of Pediatrics. He practices at University of Pittsburgh Physicians, Department of Pediatrics. Dr. Vallely received his medical degree from Campbell University School of Osteopathic Medicine and completed his residency at Eastern Virginia Medical School, followed by a fellowship at Children's Hospital Los Angeles.

Julia Leix, MD, specializes in pediatric hematology oncology. She practices at Pediatric Hematology Oncology in Lawrenceville. Dr. Leix completed her medical degree at Ross University School of Medicine, residency at Lehigh Valley Health Network, and fellowship at the University of Pittsburgh School of Medicine.